Your browser doesn't support javascript.
loading
Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients With Relapsed/Refractory Hematologic Malignancies: Model-Informed Hypothesis Generation for Pediatric Dosing Regimens.
Suri, Ajit; Mould, Diane R; Song, Gregory; Kinley, Judith; Venkatakrishnan, Karthik.
Afiliação
  • Suri A; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, USA.
  • Mould DR; Projections Research, Inc., Phoenixville, Pennsylvania, USA.
  • Song G; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, USA.
  • Kinley J; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, USA.
  • Venkatakrishnan K; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, USA.
J Clin Pharmacol ; 60(12): 1585-1597, 2020 12.
Article em En | MEDLINE | ID: mdl-32596842

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Cálculos da Dosagem de Medicamento / Antineoplásicos Imunológicos / Brentuximab Vedotin Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Cálculos da Dosagem de Medicamento / Antineoplásicos Imunológicos / Brentuximab Vedotin Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article